Institution
Henan Cancer Hospital
Also known as: 河南省肿瘤医院
- 407running trials
- 124closed trials
- 9,120publications (OpenAlex)
Running trials
Not yet recruiting
A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC
Recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma
Not yet recruiting
Recruiting
Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC
Recruiting
Recruiting
Recruiting
A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy
Not yet recruiting
Recruiting
Active, not recruiting
Recruiting
SG301-SC Injection Safety Study in Subjects With Primary ITP Patients
Not yet recruiting
Not yet recruiting
Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma
Recruiting
Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients
Recruiting
Recruiting
Not yet recruiting
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Recruiting
To Evaluate the Safety of SG2918 in Patients With Relapsed/Refractory Multiple Myeloma
Not yet recruiting
Active, not recruiting
Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) On-Demand Treatment
Recruiting
Recruiting
MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)
Recruiting
Recruiting
Recruiting
A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)
Recruiting
A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
Recruiting
Radiotherapy After Prostatectomy for Node Positive Prostate Cancer
Recruiting
Recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Zorifertinib With Osimertinib for NSCLC With Meningeal Progression
Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Active, not recruiting
HS-20093 in Patients With Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
Recruiting
A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
Showing 50 of 407.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer63 recruiting
- Gastric and oesophageal cancer35 recruiting
- Metastatic breast cancer20 recruiting
- Childhood cancers15 recruiting
- Liver and biliary tract cancer14 recruiting
- Multiple myeloma14 recruiting
- Pancreatic cancer13 recruiting
- Colorectal cancer12 recruiting
- Chronic lymphocytic leukaemia10 recruiting
- Diffuse large B-cell lymphoma10 recruiting
- Prostate cancer10 recruiting
- Endometrial cancer8 recruiting
- Immune thrombocytopenia (ITP)8 recruiting
- Triple-negative breast cancer8 recruiting
- Sarcoma7 recruiting
- Follicular lymphoma6 recruiting
- Mantle cell lymphoma6 recruiting
- Myeloproliferative neoplasms6 recruiting
- Ovarian cancer6 recruiting
- Acute myeloid leukaemia4 recruiting
- Brain metastases4 recruiting
- Thyroid cancer4 recruiting
- Acute lymphoblastic leukaemia3 recruiting
- Head and neck cancer3 recruiting
- Myelodysplastic syndromes3 recruiting
- Neuroendocrine tumours3 recruiting
- Cervical cancer2 recruiting
- Chronic myeloid leukaemia2 recruiting
- Amyloidosis1 recruiting
- Bladder cancer1 recruiting
- Cytomegalovirus infection1 recruiting
- Haemophilia1 recruiting
- Hodgkin lymphoma1 recruiting
- Melanoma1 recruiting
- Mesothelioma1 recruiting
Closed trials
Completed
ProSight: A Multi-centre Interventional Study Evaluating MCED in Asymptomatic Population
Completed
A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections
Completed
Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
Terminated
Completed
ARTEMIS-008:HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer
Completed
Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor
Completed
A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma
Completed
Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein
Completed
Completed
Completed
Terminated
TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Completed
Completed
Safety and Efficacy of TareSphere in Patients With Unresectable Hepatocellular Carcinoma
Completed
RD13-02 for Patients With r/r CD7+ T Cell Hematologic Malignancies
Terminated
A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies
Completed
Withdrawn
A Study to Evaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCC
Terminated
IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid Tumor
Withdrawn
EP0057 in Combination With Olaparib in Relapsed Advanced Gastric Cancer and Small Cell Lung Cancer
Terminated
Completed
Completed
Completed
Completed
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903
Completed
Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
A Study of PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPM
Completed
A Study of LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma
Terminated
Completed
Completed
Completed
PM8002 in Combination With Chemotherapy as First Line Therapy in Hepatocellular Carcinoma
Completed
Terminated
A Study of ATG-010 in Combination With Lenalidomide and Rituximab (R2) in Adults With DLBCL and iNHL
Completed
Terminated
Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Terminated
Terminated
A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC
Completed
Real-world Experience of ICIs Plus Chemotherapy for Advanced ESCC.
Completed
Completed
Completed
GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
Completed
Showing 50 of 124.
Registry name variants (69)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Henan Cancer Hospital
Zhengzhou, Henan 450008
438 trials
Henan Cancer Hospital
Henan, 450008
13 trials
Department of Bone and Soft Tissue ,Henan Cancer Hospital
Zhengzhou, Henan 450008
6 trials
Henan Cancer Hospital
Zhenzhou, Henan 450000
4 trials
Henan Cancer Hospital (Site 0112)
Zhengzhou, Henan 450008
2 trials
Henan Cancer Hospital (Site 0610)
Zhengzhou, Henan 450003
2 trials
Henan Cancer Hospital (Site 3105)
Zhengzhou, Henan 450008
2 trials
Henan Cancer Hospital (Site 3309)
Zhengzhou, Henan 450008
2 trials
Henan Cancer Hospital - Zhengzhou University
Zhengzhou, 450008
2 trials
Henan Cancer Hospital
Shanghai Sheng, 200032
1 trial
Henan Cancer Hospital
Zengzhou, 450003
1 trial
Contact: Principal Investigator
Henan Cancer Hospital
Zhangzhou, Henan 450003
1 trial
NCT07045311JS207 Combination Therapy in Triple-negative Breast Cancer
Contact: Min Yan, Doctor
Henan Cancer Hospital - 3226
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital-henan cancer hospital (Site 0015)
Zhengzhou, Henan 450000
1 trial
Henan Cancer Hospital-henan cancer hospital (Site 1316)
Zhengzhou, Henan 450000
1 trial
Henan Cancer Hospital-henan cancer hospital (Site 2813)
Zhengzhou, Henan 450000
1 trial
Henan Cancer Hospital-henan cancer hospital (Site 3002)
Zhengzhou, Henan 450000
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan, 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital/Second Ward of Respiratory Medicine Department
Zhengzhou, Henan 000000
1 trial
Contact: Yanqiu Zhao, Site 007-021-Ph3
Henan Cancer Hospital (Site 0127)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 0227)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 0311)
Zhengzhou, Henan 450000
1 trial
Henan Cancer Hospital (Site 0333)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 0515)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 0713)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 0718)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 0806)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 0818)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 0822)
Zhengzhou, Henan 450008
1 trial
Contact: Study Coordinator
Henan Cancer Hospital (Site 1472)
Zhengzhou, Henan 450008
1 trial
Contact: Study Coordinator
Henan Cancer Hospital (Site 1618)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 1702)
Zhengzhou, Henan 450003
1 trial
NCT07519772A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Contact: Study Coordinator
Henan Cancer Hospital (Site 2238)
Zhengzhou, Henan 450000
1 trial
Contact: Study Coordinator
Henan Cancer Hospital (Site 2400)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 2415)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 2443)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 2501)
Zhengzhou, Henan 450008
1 trial
NCT07405151A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)
Contact: Study Coordinator
Henan Cancer Hospital (Site 2746)
Zhengzhou, Henan 450008
1 trial
Contact: Study Coordinator
Henan Cancer Hospital (Site 2916)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 3108)
Zhengzhou, Henan 450008
1 trial
NCT07060807A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Contact: Study Coordinator
Henan Cancer Hospital (Site 3116)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 3149)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 3205)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 3518)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 5001)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 5026)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 5504)
Zhengzhou, Henan 450008
1 trial
Henan Cancer Hospital (Site 7504)
Zhengzhou, Henan 450000
1 trial
Contact: Study Coordinator
Henan Cancer Hospital (Site 9509)
Zhengzhou, Henan 450008
1 trial
Contact: Study Coordinator
Henan Cancer Hospital/The 1st pneumology department
Zhengzhou, 00000
1 trial
Contact: Xiufeng Hu, Site 6715
Conditions
Diseases this institution publishes on or runs trials for.
- Lung cancer173 works · 143 trials
- Gastric and oesophageal cancer83 works · 66 trials
- Brain metastases32 works · 5 trials
- Metastatic breast cancer16 works · 38 trials
- Thyroid cancer12 works · 7 trials
- Diffuse large B-cell lymphoma12 works · 27 trials
- Immune thrombocytopenia (ITP)6 works · 9 trials
- Aplastic anaemia3 works · 0 trials
Institution data: ROR 043ek5g31 (CC0-1.0)Updated 15 Nov 2026